Search

Search Constraints

You searched for: Author/Creator Delabesse, Eric

Search Results

1. Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience. (7th June 2019)

2. VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy. (10th March 2021)

3. Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors. (June 2019)

4. Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial. (18th April 2021)

5. TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia. Issue 4 (1st February 2022)

6. Epidemiology, clinical picture and long‐term outcomes of FIP1L1‐PDGFRA‐positive myeloid neoplasm with eosinophilia: Data from 151 patients. Issue 11 (19th September 2020)

7. Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study. Issue 6 (12th May 2022)

8. Outcome of relapsed/refractory AML patients with IDH1R132 mutations in real life before the era of IDH1 inhibitors. Issue 2 (28th January 2020)

9. Impact of obesity in favorable‐risk AML patients receiving intensive chemotherapy. Issue 2 (26th November 2015)

10. Epidemiology, clinical picture and long‐term outcomes of FIP1L1‐PDGFRA‐positive myeloid neoplasm with eosinophilia: Data from 151 patients. Issue 11 (19th September 2020)